Urgent Call to Action from National Security Commission on Biotechnology for America's Future
National Security Commission's Crucial Report on Biotechnology
The National Security Commission on Emerging Biotechnology delivered a critical report to Congress on April 8, 2025, emphasizing the urgent need for strategic action to safeguard U.S. national interests in the biotechnology sector. As global competition intensifies, particularly with China, the Commission argues that biotechnology is no longer just a matter of scientific progress but a pressing national security issue.
For decades, the United States has stood at the forefront of biotechnological innovation. However, the Commission's findings signal a concerning trend: the U.S. is perilously close to losing its competitive edge to China, which has been systematically prioritizing biotechnology within its national strategy. According to Senator Todd Young, chair of the Commission,